The Ozempic Shortage Explained
Ozempic, manufactured by Novo Nordisk, is a medication FDA approved for treatment of type 2 diabetes. An uptick in off-label prescription use, for indications such as Obesity, has led to an increase in demand for Ozempic. The high demand has resulted in an Ozempic shortage nationwide. The manufacturer has indicated the shortage will continue until December 2022.
Social media platform, TikTok, has also seen an uptick in hashtags and views related to Ozempic. As of September 2022, #Ozempic has 185.6 million views and the hashtag #OzempicWeightLoss with 69.9 million views.
It’s important our members continue to manage their blood glucose levels to prevent long term complications from diabetes. SmithRx is available to support our members and clients in navigating the short supply. We have sent mailers to potentially impacted members and provided covered, formulary alternatives and proactive measures to ensure members have enough medication on hand.
A new type of pharmacy benefits manager, SmithRx is working to reduce pharmacy costs by reimagining the traditional PBM as a Drug Acquisition Platform built on transparent modern technology that aligns with the needs of our customers.